You are here

Home » Content

Nadir görülen bir yan etkisi olarak risperidon ve nokturnal enürezis

Risperidone and nocturnal enuresis as a rare side effect

Journal Name:

  • Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2011

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
For children and adolescents, risperidone is proposed to be an effective agent for treating many psychiatric disorders such as psychotic disorders, pervasive developmental disorders, conduct disorder and behavioral problems accompanying mental retardation. Excessive appetite, weight gain, and sedation are among the most common adverse effects; on the other hand risperidone-induced enuresis is rarely reported. A case with risperidone-induced enuresis will be presented and the results will be discussed using a number of relevant case studies from the literature.
Bookmark/Search this post with
Abstract (Original Language): 
Çocuk ve gençlerde risperidon psikotik bozukluk, yaygın gelişimsel bozukluklar, davranım bozukluğu ve mental retardasyona eşlik eden davranış sorunları gibi birçok psikiyatrik bozukluğun tedavisinde etkin olabilecek bir ajan olarak belirtilmektedir. İştah artışı, kilo alımı ve sedasyon sık görülen yan etkiler olmasına rağmen risperidona bağlı gelişen enürezis nadir görülen bir yan etkidir. Risperidona bağlı enürezis nokturna gelişen bir olgu sunulup bulgularımız literatür bilgileri eşliğinde tartışılmıştır.
FULL TEXT (PDF): 
PDF icon arastirmax-nadir-gorulen-bir-yan-etkisi-olarak-risperidon-nokturnal-enurezis.pdf
  • 4
136-138
  • Turkish

REFERENCES

References: 

1.
Öztürk
M, Sayar K, Tüzün Ü. Asperger bozukluğu olan çocuklarda risperidon kullanımı: olgu sunumu. Klinik Psikofarmakoloji Bülteni 2000; 10(1): 51-55.
2. Took KJ, Buck BL. Enuresis with combined risperidone and SSRI use. J Am Acad Child Adolesc Psychiatry 1996; 35(7): 840-41.
3. Synder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 2002; 41(9): 1026-36.
4. Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B. Long term, open label study ofrisperidone in children with severe disruptive behaviors and below-average IQ. Am J Psychiatry 2004; 161(4): 677-84.
5. Hergüner S, Mukaddes NM. Risperidone induced enuresis in two children with autistic disorder. J Child Adolesc Psychopharmacol 2007; 17(4): 527-30.
6. Ghanizadeh A, Mohsen Kianpoor M. Cessation of risperidone-induced incontinency by valproate in a child with pervasive developmental disorder. Prim Psychiatry2007; 15(4): 32- 4.
7. Poyurovsky M, Weizman A. Risperidone induced nocturnal enuresis. Isr J Psychiatry Relat Sci 1997; 34(3): 247-48.
8. Vokas CS, Steele VM, Norris JI, Vernon LT, Brescan DW. Incidence ofrisperidone induced incontinence. SchizophrRes 1997; 24(1): 267.
9. Kandil ST, Aksu HB, Ozyavuz R. Reversible nocturnal enuresis in children receiving SSRI with or without risperidone: presentation offive cases. Isr J ofPsychiatry RelatSci 2004; 41(3): 218-21.
10. Diagnostic and Statistical Manual ofMental Disorders-Fourth edition (DSM-IV). American Psychiatric Association. Washington, Amerikan Psychiatric Press,
1994.
11. Kantrowitz JT, Srihari VH, Tek C. Three cases of risperidone-induced enuresis. Schizophr Res 2006; 84(1): 174-75.
12. Steingard S. Use ofdesmopressin to treat clozapine-induced nocturnal enuresis. J Clin Psychiatry1994; 55(7): 315-16.
13. Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Clozapine induced urinary incontinence: incidence and treatment with ephedrine. JClinPsychiatry 1996; 57(11): 517-18.

Thank you for copying data from http://www.arastirmax.com